John Schieszer

Researchers sought to assess the future landscape of treatments and cures for childhood ALL.

Researchers sought to determine whether copanlisib would have a response in patients with relapsed/refractory indolent follicular lymphoma.

Researchers investigated whether adding venetoclax to ibrutinib and obinutuzumab would improve survival and allow for discontinuation of treatment in older patients with CLL.

“Excellent” overall survival is achievable with currently available drugs, according to researchers.

The researchers examined the prognostic significance of AMC and LMR in 316 patients with MALT lymphoma.

Trastuzumab deruxtecan improved progression-free and overall survival, compared with physician’s choice of therapy.

The detection rate was 48% higher with digital breast tomosynthesis.

The risk of breakthrough SARS-CoV-2 infections was highest for liver cancer and lowest for thyroid cancer.

A nationwide survey showed stress and discontentment among nurses in general, as well as oncology nurses, may have a crippling effect on the US healthcare system.

A prospective study sought to determine the value of geriatric assessment in patients with non-Hodgkin lymphoma, compared with assessment based on chronological age.